The role of annexin A2 autoantibodies in the pathogenesis of primary nephrotic syndrome: a retrospective study based on medical records

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027202

Enrollment

Unknown

Registered

2019-11-05

Start date

2019-11-06

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary nephrotic syndrome

Interventions

Annexin A2 autoantibody positive group:No additional intervention

Annexin A2 autoantibody negative group:No additional intervention

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Nephrotic syndrome children aged 0-18 years were caused by non-genetic factors.

Exclusion criteria

Exclusion criteria: No exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Glucocorticoid sensitivity;	—

Secondary

Measure	Time frame
The length of hospital stay;urine micro-protein;U-IgG/Cr;	—

Countries

China

Contacts

Public ContactMao Jianhua

Children's Hospital, Zhejiang University School of Medicine

maojh88@zju.edu.cn+86 13516819071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026